Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Current Liabilities (2020 - 2025)

Journey Medical's Total Current Liabilities history spans 6 years, with the latest figure at $37.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 6.44% year-over-year to $37.4 million, compared with a TTM value of $37.4 million through Dec 2025, up 6.44%, and an annual FY2025 reading of $37.4 million, up 6.44% over the prior year.
  • Total Current Liabilities for Q4 2025 was $37.4 million at Journey Medical, down from $39.7 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $76.9 million in Q1 2023, with the low at $33.3 million in Q3 2024.
  • Average Total Current Liabilities over 5 years is $49.7 million, with a median of $45.2 million recorded in 2023.
  • Year-over-year, Total Current Liabilities surged 83.93% in 2021 and then tumbled 49.93% in 2024.
  • Tracing DERM's Total Current Liabilities over 5 years: stood at $51.6 million in 2021, then increased by 29.48% to $66.8 million in 2022, then plummeted by 37.35% to $41.9 million in 2023, then fell by 15.99% to $35.2 million in 2024, then increased by 6.44% to $37.4 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Total Current Liabilities are $37.4 million (Q4 2025), $39.7 million (Q3 2025), and $40.5 million (Q2 2025).